Improving Antiretroviral Management for HIV
Improving Antiretroviral Management for HIV
批准号:
8225166
负责人:
RICHARD H HAUBRICH
金额:
$19.31万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-15 至 2016-02-28
关键词:
AdherenceAfrican AmericanAnti-Retroviral AgentsAntiretroviral resistanceApplications GrantsBehaviorBehavioralCaliforniaCaregiversCensusesChlamydia trachomatisClinicalClinical ResearchCommunicable DiseasesCommunitiesDataDevelopmentDoseDrug resistanceEnsureEthnic OriginEventFacultyFailureFamily memberFundingGenderGoalsGrantHIVIncidenceIndividualIngestionInstitutional Review BoardsInternetInterventionInvestigationLaboratoriesMeasuresMentorsMethodologyMethodsMolecularNeisseria gonorrhoeaeOutcomePathogenesisPatientsPhylogenetic AnalysisPhysiciansPrevalencePrincipal InvestigatorProcessPublicationsRaceResearch Project GrantsResistanceRiskRisk FactorsRisk ReductionSamplingScienceScientistSiteSurveysSyphilisSystemTenofovirTimeTraining ProgramsWalkersWomanWorkWritingcareercohortdata sharingefavirenzemtricitabinegraduate studenthigh risk behaviorhigh risk sexual behaviorimprovedmedication compliancemeetingsmenmucosal sitenext generationnovelprotocol developmentsensorsexually activetransmission processtrend
中文摘要
描述(由申请人提供):本次K24续期申请的目的是允许申请人继续指导从事HIV临床研究的学员。该申请将提供持续的机会,通过UCSD AVRC、加州合作治疗小组(CCTG)和CFAR综合临床系统网络(CNICS),利用正在进行和计划中的临床研究指导传染病研究员、初级教师和研究生进行与HIV相关的临床研究项目,并继续扩大申请人对UCSD临床研究培训计划的参与。目标中概述的研究为深入指导以及及时调查艾滋病毒管理和发病机制中的重要科学问题提供了机会。对于每个目标和子目标,学员是研究的主要领导者:学员从一开始就与申请人一起开发研究,并将参与方案制定,研究执行,统计分析,结果解释,结果展示和出版的各个方面。所有主要研究均获资助(学员参与拨款的撰写过程),而实验室的次级目标,学员已参与最近提交的拨款申请。
英文摘要
DESCRIPTION (provided by applicant): The goal of this K24 renewal application is to allow the applicant to continue to mentor trainees pursuing a career in clinical HIV investigation. This application would provide continued opportunities to utilize ongoing and planned clinical studies to mentor Infectious Disease fellows, junior faculty and graduate students in HIV related clinical research projects through the UCSD AVRC, the California Collaborative Treatment Group (CCTG) and the CFAR Network of Integrated Clinical Systems (CNICS) and to continue to expand the applicant's participation in the UCSD training programs for clinical research. The studies outlined in the aims provide opportunities for in-depth mentoring as well as investigation of timely and important scientific questions in HIV management and pathogenesis. For each of the aims and sub-aims, a mentee is the primary leader of the study: trainees have worked with the applicant to develop the studies from the inception and will participate in every aspect of protocol development, study execution, statistical analyses, results interpretation, presentation and publication of the results. All of the main studies are funded (mentees participated in the grant writing process) and for laboratory sub-aims, trainees have participated in recently submitted grant applications.
The goal of mentoring will be achieved through the conduct of 2 scientific aims which incorporate several clinical studies. SPECIFIC AIM 1: To analyze CNICS cohort data to evaluate trends in antiretroviral (ARV) exposure and resultant virologic and resistance outcomes including disparities in outcome among women and African Americans. Clinical Studies: CNICS 002, CNICS 019 plus new CNICS concept proposal in development. SPECIFIC AIM 2: To investigate technologic and behavioral methodologies which improve adherence to ARV and reduce high-risk behavior in order to potentially reduce transmission from HIV- infected subjects. Clinical studies: CCTG 592 and new CCTG studies in development.
The goal of this project is to allow the Principal Investigator to continue to mentor trainees pursuing a career in clinical HIV investigation. This application would provide continued opportunities to utilize ongoing and planned clinical studies to mentor Infectious Disease fellows, junior faculty and graduate students in HIV related clinical research projects through the UCSD AVRC, the California Collaborative Treatment Group (CCTG) and the CFAR Network of Integrated Clinical Systems (CNICS). Ultimately, the project would help to ensure that the next generation of scientists is available to meet the challenges of improving science and treatment of HIV infected patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Screening for atherosclerotic vascular disease in HIV-infected children
-
批准号:8839837
-
项目类别:
-
资助金额:$34.45万
-
财政年份:2015
-
负责人:RICHARD H HAUBRICH
-
依托单位:
Assessing the Clinical Consequences of HIV Drug Resistance
-
批准号:7555003
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2008
-
负责人:RICHARD H HAUBRICH
-
依托单位:
Assessing the Clinical Consequences of HIV Drug Resistance
-
批准号:7690947
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2008
-
负责人:RICHARD H HAUBRICH
-
依托单位:
Clinical Investigation
-
批准号:7635789
-
项目类别:
-
资助金额:$22.42万
-
财政年份:2008
-
负责人:RICHARD H HAUBRICH
-
依托单位:
Clinical Investigation
-
批准号:7278950
-
项目类别:
-
资助金额:$23.3万
-
财政年份:2007
-
负责人:RICHARD H HAUBRICH
-
依托单位:
Improving Antiretroviral Management for HIV
-
批准号:8848023
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2006
-
负责人:RICHARD H HAUBRICH
-
依托单位:
Improving Antiretroviral Management for HIV
-
批准号:7064358
-
项目类别:
-
资助金额:$15.48万
-
财政年份:2006
-
负责人:RICHARD H HAUBRICH
-
依托单位:
ACTG A5142 LOPINAVIR/RITONAVIR PLUS EFAVIRENZ FOR HIV-1 INFECTION
-
批准号:7374177
-
项目类别:
-
资助金额:$1.17万
-
财政年份:2006
-
负责人:RICHARD H HAUBRICH
-
依托单位:
Improving Antiretroviral Management for HIV
-
批准号:8140837
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2006
-
负责人:RICHARD H HAUBRICH
-
依托单位:
Improving Antiretroviral Management for HIV
-
批准号:7578888
-
项目类别:
-
资助金额:$16.94万
-
财政年份:2006
-
负责人:RICHARD H HAUBRICH
-
依托单位:
Improving Antiretroviral Management for HIV
-
批准号:8423355
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2006
-
负责人:RICHARD H HAUBRICH
-
依托单位:
Improving Antiretroviral Management for HIV
-
批准号:8623093
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2006
-
负责人:RICHARD H HAUBRICH
-
依托单位:
Improving Antiretroviral Management for HIV
-
批准号:7380061
-
项目类别:
-
资助金额:$16.1万
-
财政年份:2006
-
负责人:RICHARD H HAUBRICH
-
依托单位:
ACTG A5142 LOPINAVIR/RITONAVIR PLUS EFAVIRENZ FOR HIV -1 INFECTION
-
批准号:7606527
-
项目类别:
-
资助金额:$0.33万
-
财政年份:2006
-
负责人:RICHARD H HAUBRICH
-
依托单位:
ACTG A5079 PHYSIOLOGIC TESTOSTERONE SUPPLEMENTATION IN HIV
-
批准号:7374162
-
项目类别:
-
资助金额:$0.39万
-
财政年份:2006
-
负责人:RICHARD H HAUBRICH
-
依托单位:
Improving Antiretroviral Management for HIV
-
批准号:7195818
-
项目类别:
-
资助金额:$15.97万
-
财政年份:2006
-
负责人:RICHARD H HAUBRICH
-
依托单位:
ACTG A5142 LOPINAVIR/RITONAVIR PLUS EFAVIRENZ FOR HIV-1 INFECTION
-
批准号:7045466
-
项目类别:
-
资助金额:$0.44万
-
财政年份:2003
-
负责人:RICHARD H HAUBRICH
-
依托单位:
ACTG A5079 PHYSIOLOGIC TESTOSTERONE SUPPLEMENTATION IN HIV
-
批准号:7205600
-
项目类别:
-
资助金额:$1.17万
-
财政年份:2003
-
负责人:RICHARD H HAUBRICH
-
依托单位:
ACTG A5142 LOPINAVIR/RITONAVIR PLUS EFAVIRENZ FOR HIV-1 INFECTION
-
批准号:7205632
-
项目类别:
-
资助金额:$1.33万
-
财政年份:2003
-
负责人:RICHARD H HAUBRICH
-
依托单位:
ACTG A5079 Physiologic Testosterone Supplements in HIV
-
批准号:7045423
-
项目类别:
-
资助金额:$1.82万
-
财政年份:2003
-
负责人:RICHARD H HAUBRICH
-
依托单位:
海外基金